Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Shenzhen Salubris Pharmaceuticals Co., Ltd.

Market Cap 3.49TCr 514.7Cr 445.47Cr 410.68Cr 384.2Cr 716.92Cr 49TCr 733.04Cr 4.88TCr 1.89TCr 24TCr 1.93TCr 1.89TCr 83TCr P/E Ratio 2026 *
41.7x
P/E Ratio 2027 * 37.2x
Enterprise Value 3.49TCr 514.7Cr 445.47Cr 410.68Cr 384.2Cr 716.92Cr 49TCr 733.04Cr 4.88TCr 1.89TCr 24TCr 1.93TCr 1.89TCr 83TCr EV / Sales 2026 *
6.4x
EV / Sales 2027 * 5.2x
Free-Float
38.48%
Yield 2026 *
-
Yield 2027 * -
1 day-0.60%
1 week-3.25%
Current month-6.40%
1 month-34.70%
3 months-42.08%
6 months-47.05%
Current year-36.87%
1 week 30.66
Extreme 30.66
33.42
1 month 30.66
Extreme 30.66
41.6
Current year 30.66
Extreme 30.66
70.99
1 year 30.66
Extreme 30.66
70.99
3 years 23.5
Extreme 23.5
70.99
5 years 20
Extreme 20
70.99
10 years 16.7
Extreme 16.7
70.99
Manager TitleAgeSince
Chief Executive Officer 53 23/09/2022
Director of Finance/CFO 52 30/12/2021
Chief Administrative Officer 50 01/01/2006
Director TitleAgeSince
Chairman 82 03/11/1998
Chairman 51 23/09/2022
Director/Board Member 50 20/08/2010
Date Insider Type Main position Quantity % Market Cap.
20/20/20Buy

Chief Executive Officer

28,300 0.0027%
20/20/20Buy

Director

28,100 0.0027%
19/20/19Buy

Chief Financial Officer

36,000 0.0034%
Change 5-day change 1-year change 3-year change Capi.($)
-0.60%-3.25%-38.30%-6.40% 514.7Cr
+0.74%+1.12%+6.47%+82.66% 4.5TCr
-0.44%-5.15%+39.12%+87.63% 3.37TCr
+0.47%+1.68%+12.67%+116.24% 1.16TCr
+0.82%-0.73%-8.75%+44.64% 1.17TCr
+0.59%+0.39%+36.17%+125.55% 894.45Cr
-0.85%-1.94%+15.12%+39.86% 700.72Cr
+1.02%-0.67%+32.44%+239.19% 635.21Cr
+0.61%+1.91%+41.79%-17.68% 651.35Cr
+0.71%+5.09%+17.03%+115.31% 403.09Cr
Average +0.30%-0.24%+15.38%+82.70% 1.4TCr
Weighted average by Cap. +0.31%-1.58%+17.39%+84.16%

Financials

2026 *2027 *
Net sales 544.6Cr 80Cr 70Cr 64Cr 60Cr 111.96Cr 7.66TCr 114.48Cr 761.98Cr 295.51Cr 3.71TCr 301.74Cr 295.26Cr 13TCr 670.8Cr 99Cr 86Cr 79Cr 74Cr 137.91Cr 9.43TCr 141.01Cr 938.56Cr 363.99Cr 4.57TCr 371.66Cr 363.68Cr 16TCr
Net income 74Cr 11Cr 9.49Cr 8.75Cr 8.19Cr 15Cr 1.04TCr 16Cr 103.96Cr 40Cr 505.97Cr 41Cr 40Cr 1.76TCr 94Cr 14Cr 12Cr 11Cr 10Cr 19Cr 1.31TCr 20Cr 130.82Cr 51Cr 636.72Cr 52Cr 51Cr 2.21TCr
Net Debt - -
Logo Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shenzhen Salubris Pharmaceuticals Co Ltd is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals and medical devices. The Company's main products include cardiovascular drugs and medical devices, cephalosporin antibiotics and raw materials, orthopedic drugs and others. The Company's productpipeline covers key areas of interventional therapy such as cardiovascular and cerebrovascular diseases, peripheral blood vessels, structural heart diseases, electrophysiology and cardiac rhythm management. The Company's products are mainly used in the treatment of cardiovascular and cerebrovascular diseases, hypoglycemic, nephrology, orthopedics and anti-tumor. The Company distributes its products within domestic market and to overseas markets.
Employees
4,087
Date Price Change Volume
10/26/10 31.28 ¥ -0.60% 1,29,69,980
09/26/09 31.47 ¥ +0.80% 1,42,58,606
08/26/08 31.22 ¥ -3.28% 1,84,05,077
05/26/05 32.28 ¥ +0.59% 2,07,72,170
04/26/04 32.09 ¥ -0.74% 1,23,48,100
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
31.28
Average target price
-

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002294 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!